Liberate Medical Secures $6.2M in Series B Financing — Liberate Medical
CRESTWOOD, KY, 5 July 2023: Liberate Medical, an emerging leader in the development of novel non-invasive neurostimulation devices focused on transforming respiratory care, announced today the successful closure of its $6.2M Series B financing round. The funding was co-led by a large strategic investor and Scientific Health Development, who will both join Liberate Medical’s Board, […]
Liberate Medical Secures $6.2M in Series B Financing — Liberate Medical Read More »







